Donanemab-Azbt

19 interactions 1 explained in plain English
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 11, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Apixaban Betrixaban Heparin Dabigatran Etexilate Dalteparin Injection Heparin Injection
12 Major 7 Moderate
All (19) Major (12) Moderate (7)

Major

Donanemab-Azbt Apixaban Eliquis Explained An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Donanemab-Azbt Betrixaban Bevyxxa® An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Donanemab-Azbt Dabigatran Pradaxa® An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Donanemab-Azbt Dabigatran Etexilate An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Donanemab-Azbt Dalteparin Injection Fragmin An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Donanemab-Azbt Edoxaban Savaysa An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Donanemab-Azbt Enoxaparin Lovenox An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Donanemab-Azbt Enoxaparin Injection Lovenox An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Donanemab-Azbt Fondaparinux Arixtra An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Donanemab-Azbt Fondaparinux Injection Arixtra An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Donanemab-Azbt Heparin An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Donanemab-Azbt Heparin Injection Lipo-Hepin® An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details

Moderate

Donanemab-Azbt Aspirin Acuprin® An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Donanemab-Azbt Aspirin Rectal Aspirin An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Donanemab-Azbt Anagrelide Agrylin An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Donanemab-Azbt Clopidogrel Plavix An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Donanemab-Azbt Dipyridamole Permole® An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Donanemab-Azbt Epoprostenol Flolan An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Donanemab-Azbt Iloprost Aurlumyn An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.